In addition to the previously announced US FDA approval for the conduct of the study, Health Canada’s Health Products and Food Branch has also approved this study, which will be conducted at clinical sites in Miami, Philadelphia, and Quebec City.
除了美国FDA之前宣布批准研究外，加拿大卫生部健康产品食品股也批准研究，研究将在迈阿密、费城和魁北克市的临床地点进行。